İbrahim Ethem PINAR,
Vildan OZKOCAMAN
Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma
Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma
The European Research Journal
2023-Cilt: 9 Sayı: 6 - November 2023
1483-1492
Ibrutinib,
efficiency,
safety,
chronic lymphocytic leukemia,
mantle-cell lymphoma
365
405